Dr. De Lima is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11100 Euclid Ave
Cleveland, OH 44106Phone+1 216-844-3951
Education & Training
- University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 1994 - 1997
- Fed Univ Rio de Janeiro- Sch Med SciClass of 1986
Certifications & Licensure
- TX State Medical License 1998 - 2026
- OH State Medical License 2012 - 2025
Publications & Presentations
PubMed
- 39 citationsCardiovascular Events Associated with Chimeric Antigen Receptor T Cell Therapy: Cross-Sectional FDA Adverse Events Reporting System AnalysisAvirup Guha, Daniel Addison, Prantesh Jain, Jahir M. Gutierrez, Arjun K. Ghosh
Biology of Blood and Marrow Transplantation. 2020-12-01 - 114 citationsProceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse After Hematopoietic Stem Cell Trans...Marcos de Lima, David L. Porter, Minoo Battiwalla, Michael R. Bishop, Sergio Giralt
Biology of Blood and Marrow Transplantation. 2014-01-01 - 238 citationsEight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide...Issa F. Khouri, Peter McLaughlin, Rima M. Saliba, Chitra Hosing, Martin Korbling
Blood. 2008-06-15
Lectures
- Preclinical Studies and a Phase I Trial of the TGF-β Receptor Inhibitor, Vactosertib (TEW-7197), in Combination with Pomalidomide in Patients with Multiple Myeloma Ref...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- The Direction of KIR Ligand Incompatibility Is Associated with Graft Failure and May Predict the Dominant Donor Following Double Umbilical Cord Blood Transplantation2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Impact of Maintenance Therapy on Nature of First Relapse in Multiple Myeloma Patients Underwent Autologous Stem Cell Transplant2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: